FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Vetter

Research Profile

Living Beings

Anatomy

Disorders

Chemicals & Drugs

Physiology

Procedures

Diagnosis, Differential

Co-author Network

Publications

TOP 3
Nadine Müller; Sabine Ellinger; Birgit Alteheld; Gudrun Ulrich-Merzenich; Heiner K Berthold; Hans Vetter; Peter Stehle
Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers.
Gudrun Ulrich-Merzenich; Darius Panek; H Zeitler; Hans Vetter; H Wagner
Drug development from natural products: exploiting synergistic effects.
Gudrun Ulrich-Merzenich; Darius Panek; Heike Zeitler; H Wagner; Hans Vetter
New perspectives for synergy research with the "omic"-technologies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Vetter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Nadine Müller; Sabine Ellinger; Birgit Alteheld; Gudrun Ulrich-Merzenich; Heiner K Berthold; Hans Vetter; Peter Stehle
Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers.
Molecular nutrition & food research 2010;54(11):1636-45.
2010: Gudrun Ulrich-Merzenich; Darius Panek; H Zeitler; Hans Vetter; H Wagner
Drug development from natural products: exploiting synergistic effects.
Indian journal of experimental biology 2010;48(3):208-19.
2009: Gudrun Ulrich-Merzenich; Darius Panek; Heike Zeitler; H Wagner; Hans Vetter
New perspectives for synergy research with the "omic"-technologies.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2009;16(6-7):495-508.
2009: Gudrun Ulrich-Merzenich; Heike Zeitler; Hans Vetter; Karin Kraft
Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2009;16(1):2-16.
2008: Heike Zeitler; Gudrun Ulrich-Merzenich; Dirk Frank Richter; Hans Vetter; Peter Walger
Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment?
Obesity surgery 2008;18(10):1354-6.
2008: Matthias F Seidel; Bernd L Fiebich; Gudrun Ulrich-Merzenich; Eduardo Candelario-Jalil; Franz-Walter Koch; Hans Vetter
Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells.
Rheumatology international 2008;28(10):1017-22.
2008: Volker Harth; Martin Schafer; Josef Abel; Laura Maintz; Thomas Neuhaus; Mette Besuden; Robert Primke; Anja Wilkesmann; Ricarda Thier; Hans Vetter; Yon-Dschun Ko; Thomas Bruning; Hermann M Bolt; Katja Ickstadt
Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
Journal of toxicology and environmental health. Part A 2008;71(13-14):887-97.
2008: Katja Ickstadt; Martin Schäfer; Arno Fritsch; Holger Schwender; Josef Abel; Hermann M Bolt; Thomas Brüning; Yon-Dschun Ko; Hans Vetter; Volker Harth
Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.
Journal of toxicology and environmental health. Part A 2008;71(11-12):803-15.
2008: Uwe R Juergens; Kurt Racké; Sakir Uen; Susanne Haag; Fathi Lamyel; Meinolf Stöber; Adrian Gillissen; Natalija Novak; Hans Vetter
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
Pulmonary pharmacology & therapeutics 2008;21(3):533-9.
2008: Stefan Pabst; Bernd Wollnik; Edyta Rohmann; Y Hintz; K Glänzer; Hans Vetter; Georg Nickenig; Christian Grohé
A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(1):39-42.
2008: Imke Beier; Rainer Düsing; Hans Vetter; Udo Schmitz
Epidermal growth factor stimulates Rac1 and p21-activated kinase in vascular smooth muscle cells.
Atherosclerosis 2008;196(1):92-7.
2007: Gudrun Ulrich-Merzenich; Heike Zeitler; Hans Vetter; Ramesh R Bhonde
Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins.
European journal of nutrition 2007;46(8):431-8.
2007: Gudrun Ulrich-Merzenich; Heike Zeitler; Darius Panek; Dirk Bokemeyer; Hans Vetter
Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway.
European journal of nutrition 2007;46(2):87-94.
2007: Sakir Uen; ismail un; Rolf Fimmers; Hans Vetter; Thomas Mengden
[Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].
Deutsche medizinische Wochenschrift (1946) 2007;132(3):81-6.
2007: Gudrun Ulrich-Merzenich; Heike Zeitler; Detmar Jobst; Darius Panek; Hans Vetter; H Wagner
Application of the "-Omic-" technologies in phytomedicine.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2007;14(1):70-82.
2006: Johannes Baulmann; Rami Homsi; Sakir Uen; Rainer Düsing; Rolf Fimmers; Hans Vetter; Thomas Mengden
Pulse wave velocity is increased in patients with transient myocardial ischemia.
Journal of hypertension 2006;24(10):2085-90.
2006: Sebastian Stier; Thomas Neuhaus; Peter Albers; Nicolas Wernert; Elisabeth Grünewald; Randolf Forkert; Hans Vetter; Yon Ko
Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
Archives of toxicology 2006;80(10):713-8.
2006: Heike Zeitler; Gudrun Ulrich-Merzenich; Lars Hoffmann; Cornelia Kornblum; Stephan Schmidt; Hans Vetter; Peter Walger
Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.
Artificial organs 2006;30(8):597-605.
2006: Sakir Uen; ismail un; Rolf Fimmers; Hans Vetter; Thomas Mengden
Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability.
Blood pressure monitoring 2006;11(4):173-82.
2006: Stefan Pabst; Georg Baumgarten; A Stremmel; M Lennarz; P Knüfermann; A Gillissen; Hans Vetter; Christian Grohé
Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.
Clinical and experimental immunology 2006;143(3):420-6.
2006: Heike Zeitler; Gudrun Ulrich-Merzenich; Peter Walger; Rainer Düsing; Hans Vetter; Hans H Brackmann
[The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A].
Deutsche medizinische Wochenschrift (1946) 2006;131(4):141-7.
2006: Silke Ewald; Johannes vor dem Esche; Sakir Uen; Fabian Neikes; Hans Vetter; Thomas Mengden
Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study.
Clinical drug investigation 2006;26(8):439-46.
2006: Uwe R Juergens; Adrian Gillissen; Sakir Uen; Kurt Racké; Meinolf Stöber; Wilfried Darlath; Hans Vetter
New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro.
Pharmacology 2006;78(3):129-35.
2006: Thomas Mengden; Hans Vetter; Eric Tousset; Sakir Uen
Management of patients with uncontrolled arterial hypertension--the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTZ.
BMC cardiovascular disorders 2006;6():36.
2006: Matthias F Seidel; Franz-Walter Koch; Hans Vetter
Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture medium.
Rheumatology international 2006;26(3):244-51.
2006: Uwe R Juergens; Wilfried Darlath; Meinolf Stober; Kurt Racké; Selçuk Tasci; Adrian Gillissen; Hans Vetter
Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes.
Pharmacology 2006;76(1):40-5.
2005: Sebastian Stier; Caroline Koll; Thomas Neuhaus; Stefan Fronhoffs; Randolf Forkert; Arja Tuohimaa; Hans Vetter; Yon Ko
Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Anti-cancer drugs 2005;16(10):1115-21.
2005: Sebastian Stier; Gudrun Totzke; Elisabeth Gruewald; Thomas Neuhaus; Stefan Fronhoffs; Silke Schoneborn; Hans Vetter; Yon Ko
Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells.
Journal of biochemistry and molecular biology 2005;38(4):447-56.
2005: Stefan Pabst; Sebastian Stier; Hans Vetter; Christian Grohé
[Small cell bronchial carcinoma. Main symptoms: cough, hemoptysis, hoarseness, dyspnea, paraneoplastic syndrome., weight loss, neurologic manifestations and post-stenotic pneumonia].
Praxis 2005;94(20):803-9; quiz 810.
2005: Heike Zeitler; Gudrun Ulrich-Merzenich; Lothar Hess; Eligius Konsek; Christoph Unkrig; Peter Walger; Hans Vetter; Hans H Brackmann
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.
Blood 2005;105(6):2287-93.
2005: Yon Ko; Tanja Hahn; Hong Lu; Zhan-Lu Ma; Jian Chen; Marcus Rothe; Alexandra Florin; Stefan Fronhoffs; Peter Albers; Agapios Sachinidis; Hans Vetter; Annette Kaminski; Peter Behrens; Axel Wellmann; Nicolas Wernert
A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer.
International journal of molecular medicine 2005;15(2):183-96.
2004: Stefan Pabst; Sebastian Stier; Hans Vetter; Christian Grohé
[Non-small-cell lung carcinoma].
Praxis 2004;93(50):2085-92.
2004: Thomas Mengden; Silke Ewald; Stefanie Kaufmann; Johannes vor dem Esche; Sakir Uen; Hans Vetter
Telemonitoring of blood pressure self measurement in the OLMETEL study.
Blood pressure monitoring 2004;9(6):321-5.
2004: Sakir Uen; Johannes Baulmann; Rainer Düsing; Hans Vetter; Thomas Mengden
[24-hour blood pressure and ECG monitoring in patients with arterial hypertonia -- importance of silent myocardial ischemia].
Deutsche medizinische Wochenschrift (1946) 2004;129(46):2482-5.
2004: Stefan Pabst; Hans Vetter; Christian Grohé
[Sarcoidosis (Boeck's disease). Inflammatory granulomatous systemic disease which involves especially the lung and lymph nodes].
Praxis 2004;93(42):1717-22; quiz 1723-4.
2004: Stefan Pabst; Hans Vetter; Christian Grohé; A Wellmann
[Bronchiolitis obliterans with organizing pneumonia (BOOP). Influenza simulating illness with opacity spots in the roentgen image (with no response to antibiotics].
Praxis 2004;93(38):1531-6; quiz 1537.
2004: Uwe R Juergens; F Jäger; Wilfried Darlath; Meinolf Stöber; Hans Vetter; Adrian Gillissen
Comparison of in vitro-activity of commonly used topical glucocorticoids on cytokine- and phospholipase inhibition.
European journal of medical research 2004;9(8):383-90.
2004: Uwe R Juergens; Meinolf Stöber; H Libertus; Wilfried Darlath; Adrian Gillissen; Hans Vetter
Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
European journal of medical research 2004;9(7):365-70.
2004: Thomas Neuhaus; G Geisen; H M Bolt; V Janzen; A Kraemer; Hans Vetter; Yon Ko
Reliability of non-invasively acquired human genomic DNA as a substrate for real-time PCR-assisted analysis of genetic polymorphisms.
Archives of toxicology 2004;78(7):390-6.
2004: Y Breuer; Hans Vetter; Burkhard Weisser; Katja Lottermoser; I Reiter-Owona
[Acute toxoplasmosis. Leading symptoms: mostly asymptomatic, cervical lymphadenopathy].
Praxis 2004;93(25-26):1079-84, 1117.
2004: Beate Pesch; Rainer Düsing; Sylvia Rabstein; Volker Harth; Dagmar Grentrup; Thomas Brüning; Olfert Landt; Hans Vetter; Yon-Dschun Ko
Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians.
Toxicology letters 2004;151(1):283-90.
2004: Thomas Neuhaus; Yon-Dschun Ko; Katrin Lorenzen; Stefan Fronhoffs; Volker Harth; Peter Bröde; Hans Vetter; Hermann M Bolt; Beate Pesch; Thomas Brüning
Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer.
Toxicology letters 2004;151(1):273-82.
2004: Stefan Pabst; Burkhard Weisser; Hans Vetter; Christian Grohé
[Extrinsic allergic alveolitis].
Praxis 2004;93(16):643-8.
2004: Udo Schmitz; Kerstin Thömmes; Imke Beier; Rainer Düsing; Hans Vetter
Identification of Nck interacting proteins in vascular smooth muscle cells.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(3):267-75.
2004: Stefan Pabst; Hans Vetter; Burkhard Weisser; Rainer Düsing
[Thromboangiitis obliterans (M. Winiwarter-Buerger). Main symptoms: acral cyanosis and aches].
Praxis 2004;93(10):353-8.
2004: Thomas Neuhaus; Stefan Fronhoffs; Hans Vetter; C Grohé
[Chronic active sarcoidosis with pleural effusion].
Pneumologie (Stuttgart, Germany) 2004;58(3):159.
2004: Johannes Baulmann; R Homsi; S Un; Hans Vetter; Rainer Düsing; Thomas Mengden
[Arterial stiffness in arterial hypertension. A new risk factor for left ventricular hypertrophy and cardiac insufficiency?].
Deutsche medizinische Wochenschrift (1946) 2004;129(9):447-52.
2004: R Böhringer; C Krautmacher; Hans Vetter; Burkhard Weisser
[Actinomycosis].
Praxis 2004;93(6):177-82.
2004: Christian Grohé; S Kann; L Fink; P Chryso Djoufack; M Paehr; Martin van Eickels; Hans Vetter; Rainer Meyer; Klaus B Fink
17 Beta-estradiol regulates nNOS and eNOS activity in the hippocampus.
Neuroreport 2004;15(1):89-93.
2004: Thomas Neuhaus; Stefan Pabst; Sebastian Stier; Artur-Aron Weber; Karsten Schrör; Agapios Sachinidis; Hans Vetter; Yon-Dschun Ko
Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate.
European journal of pharmacology 2004;483(2-3):223-7.
2004: Uwe R Juergens; Tanja Engelen; Kurt Racké; Meinolf Stöber; Adrian Gillissen; Hans Vetter
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes.
Pulmonary pharmacology & therapeutics 2004;17(5):281-7.
2004: Katja Lottermoser; Hans-Joerg Hertfelder; Peter Gohlke; Hans Vetter; Rainer Düsing
Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(1):13-26.
2003: Katja Lottermoser; Gudrun Ulrich-Merzenich; Hans Vetter; Rainer Düsing
[Effects of angiotensin II on inflammation mediators in healthy subjects].
Deutsche medizinische Wochenschrift (1946) 2003;128(47):2470-5.
2003: S Un; Johannes Baulmann; Burkhard Weisser; Rainer Düsing; Hans Vetter; Thomas Mengden
[Circadian rhythm of silent myocardial ischemia. Why morning is so risky for hypertensive patients].
MMW Fortschritte der Medizin 2003;145(47):34-8.
2003: Thomas Mengden; Sakir Uen; Hans Vetter
Morning blood pressure surge and the risk of stroke.
Circulation 2003;108(15):e110-1; author reply e110-1.
2003: Thomas Neuhaus; Christoph Lutz; Sebastian Stier; Gudrun Totzke; Elisabeth Gruenewald; Stefan Fronhoffs; Agapios Sachinidis; Hans Vetter; Yon-Dschun Ko
The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cells.
Molecular and cellular probes 2003;17(5):245-52.
2003: Simone Nuedling; Martin van Eickels; Axel Alléra; Pieter A Doevendans; Rainer Meyer; Hans Vetter; Christian Grohé
17 Beta-estradiol regulates the expression of endothelin receptor type B in the heart.
British journal of pharmacology 2003;140(1):195-201.
2003: Thomas Mengden; Sakir Uen; Johannes Baulmann; Hans Vetter
Significance of blood pressure self-measurement as compared with office blood pressure measurement and ambulatory 24-hour blood pressure measurement in pharmacological studies.
Blood pressure monitoring 2003;8(4):169-72.
2003: Katja Lottermoser; Thomas Unger; Peter Gohlke; Hans Vetter; Rainer Düsing
Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans.
American journal of hypertension 2003;16(6):445-52.
2003: Sakir Uen; Johannes Baulmann; Rainer Düsing; Kilian Glänzer; Hans Vetter; Thomas Mengden
ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring.
Journal of hypertension 2003;21(5):977-83.
2003: Thomas Neuhaus; Sebastian Stier; Gudrun Totzke; Elisabeth Gruenewald; Stefan Fronhoffs; Agapios Sachinidis; Hans Vetter; Yon-Dschun Ko
Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation.
Cell proliferation 2003;36(2):75-86.
2003: Burkhard Weisser; Hans Vetter; Thomas Mengden
[Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
Deutsche medizinische Wochenschrift (1946) 2003;128(11):541-4.
2003: Uwe R Juergens; U Dethlefsen; G Steinkamp; Adrian Gillissen; R Repges; Hans Vetter
Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial.
Respiratory medicine 2003;97(3):250-6.
2003: Sakir Uen; Hans Vetter; Thomas Mengden
Simultaneous recording of blood pressure and ST-segment with combined, triggered ambulatory 24-h devices.
Blood pressure monitoring 2003;8(1):41-4.
2003: Burkhard Weisser; Hans Vetter
[Subacute de Quervain thyroiditis].
Praxis 2003;92(1-2):3-4; quiz 5.
2003: Matthias Wenghoefer; Beate Pesch; Volker Harth; Peter Broede; Stefan Fronhoffs; Olfert Landt; Thomas Brüning; Josef Abel; Hermann M Bolt; Claus Herberhold; Hans Vetter; Yon-Dschun Ko
Association between head and neck cancer and microsomal epoxide hydrolase genotypes.
Archives of toxicology 2003;77(1):37-41.
2002: Udo Schmitz; Hans Vetter; Rainer Düsing
[Intracellular signal transduction of angiotensin II and possible interventions in the renin-angiotensin system].
Deutsche medizinische Wochenschrift (1946) 2002;127(45):2400-3.
2002: Johannes Baulmann; Rainer Düsing; Hans Vetter; Thomas Mengden
[Therapy resistant hypertension--significance of electronic compliance monitoring].
Deutsche medizinische Wochenschrift (1946) 2002;127(45):2379-82.
2002: Sakir Uen; Burkhard Weisser; Paul Wieneke; Hans Vetter; Thomas Mengden
Evaluation of the performance of a wrist blood pressure measuring device with a position sensor compared to ambulatory 24-hour blood pressure measurements.
American journal of hypertension 2002;15(9):787-92.
2002: Thomas Zander; Willy Nettekoven; Jürgen A Kraus; Hendrik Pels; Yon-Dschun Ko; Hans Vetter; Thomas Klockgether; Uwe Schlegel
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
Journal of neurology 2002;249(8):1055-7.
2002: Rolf Kaiser; Oliver Geulen; Bertfried Matz; Hans H Brackmann; Ulrich Spengler; Michael H Kramer; Martin Exner; Wilhelm Nettekoven; Yon-Dschun Ko; Heike Zeitler; Hans Vetter
Risk of hepatitis C after immunoadsorption.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(6):342-3.
2002: Gudrun Ulrich-Merzenich; Christine Metzner; Ramesh R Bhonde; Gerhard Malsch; Beate Schiermeyer; Hans Vetter
Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins.
In vitro cellular & developmental biology. Animal 2002;38(5):265-72.
2002: Stefan Fronhoffs; Gudrun Totzke; Sebastian Stier; Nicolas Wernert; Marcus Rothe; Thomas Brüning; B Koch; Agapios Sachinidis; Hans Vetter; Yon Ko
A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction.
Molecular and cellular probes 2002;16(2):99-110.
2002: Nicolas Wernert; Hans-Peter Justen; Marcus Rothe; Peter Behrens; Stephan Dreschers; Thomas Neuhaus; Alexandra Florin; Agapios Sachinidis; Hans Vetter; Yon Ko
The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis.
Journal of molecular medicine (Berlin, Germany) 2002;80(4):258-66.
2002: Udo Schmitz; Kerstin Thömmes; Imke Beier; Hans Vetter
Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells.
Biochemical and biophysical research communications 2002;291(3):687-91.
2002: Gudrun Ulrich-Merzenich; Christine Metzner; Beate Schiermeyer; Hans Vetter
Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation.
European journal of nutrition 2002;41(1):27-34.
2002: Georg Nickenig; Frank Michaelsen; Cornelius Müller; Anja Berger; Thomas Vogel; Agapios Sachinidis; Hans Vetter; Michael Böhm
Destabilization of AT(1) receptor mRNA by calreticulin.
Circulation research 2002;90(1):53-8.
2002: Annette Reissinger; Michael Ludwig; Boris Utsch; Astrid Prömse; Johannes Baulmann; Burkhard Weisser; Hans Vetter; Herbert kramer; Dirk Bokemeyer
Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles.
Kidney & blood pressure research 2002;25(6):354-62.
2001: Thomas Mengden; S Un; A Tissler; Rainer Düsing; Hans Vetter; Miklós Illyés
[The virtual hypertension clinic--telemedicine in the management of arterial hypertension].
Deutsche medizinische Wochenschrift (1946) 2001;126(47):1335-41.
2001: Katja Lottermoser; H U Schweikert; Udo Schmitz; Hans Vetter
[Fifty-three year old patient with tetany].
Der Internist 2001;42(10):1413-7.
2001: Katja Lottermoser; S Petras; U Pöge; R Fimmers; Hans-Joerg Hertfelder; B Schiermeyer; Hans Vetter; Rainer Düsing
The fibrinolytic system in chronic renal failure.
European journal of medical research 2001;6(9):372-6.
2001: Stefan Fronhoffs; Thomas Brüning; E Ortiz-Pallardo; Peter Bröde; B Koch; Volker Harth; Agapios Sachinidis; Hermann M Bolt; Claus Herberhold; Hans Vetter; Yon Ko
Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck.
Carcinogenesis 2001;22(9):1405-12.
2001: Simone Nuedling; Richard H Karas; Michael Mendelsohn; J A Katzenellenbogen; Benita S Katzenellenbogen; Rainer Meyer; Hans Vetter; Christian Grohé
Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes.
FEBS letters 2001;502(3):103-8.
2001: Thomas Mengden; Hans Vetter; András Tislér; Miklós Illyés
Tele-monitoring of home blood pressure.
Blood pressure monitoring 2001;6(4):185-9.
2001: Thomas Neuhaus; Hans-Joerg Hertfelder; Lothar Hess; Johannes Oldenburg; Peter Walger; Hans Vetter
[An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].
Deutsche medizinische Wochenschrift (1946) 2001;126(25-26):754-6.
2001: Udo Schmitz; Kerstin Thömmes; Imke Beier; W Wagner; Agapios Sachinidis; Rainer Düsing; Hans Vetter
Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck.
The Journal of biological chemistry 2001;276(25):22003-10.
2001: Gudrun Totzke; Christine Metzner; Gudrun Ulrich-Merzenich; Yon Ko; Agapios Sachinidis; Hans Vetter
Effect of vitamin E and vitamin C on the DNA synthesis of human umbilical arterial endothelial cells.
European journal of nutrition 2001;40(3):121-6.
2001: Katja Lottermoser; Rainer Düsing; P Ervens; B Koch; T Brüning; Agapios Sachinidis; Hans Vetter; Yon Ko
The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians.
Journal of molecular medicine (Berlin, Germany) 2001;79(5-6):289-93.
2001: Yon Ko; Josef Abel; Volker Harth; Peter Bröde; C Antony; S Donat; Hans-Peter Fischer; M E Ortiz-Pallardo; Ricarda Thier; Agapios Sachinidis; Hans Vetter; Hermann M Bolt; Claus Herberhold; Thomas Brüning
Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
Cancer research 2001;61(11):4398-404.
2001: Randolf Forkert; Yon Ko; Stefan Fronhoffs; K Tschubel; Hans Vetter
[Chronic progressive polycythemia and thrombocytosis].
Praxis 2001;90(17):741-6.
2001: Ioanna Gouni-Berthold; Heiner K. Berthold; Claudia Seul; Yon Ko; Hans Vetter; Agapios Sachinidis
Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth.
British journal of pharmacology 2001;132(8):1725-34.
2001: Volker Harth; Thomas Brüning; Josef Abel; B Koch; I Berg; Agapios Sachinidis; Hermann M Bolt; Hans Vetter; Yon Ko
Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms.
Molecular and cellular probes 2001;15(2):93-7.
2001: Ioanna Gouni-Berthold; Heiner K. Berthold; AA Weber; Yon Ko; Claudia Seul; Hans Vetter; Agapios Sachinidis
Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(2):215-21.
2001: Ioanna Gouni-Berthold; Heiner K. Berthold; AA Weber; Claudia Seul; Hans Vetter; Agapios Sachinidis
Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2001;109(4):203-9.
2000: Katja Lottermoser; Hans-Joerg Hertfelder; Hans Vetter; Rainer Düsing
[Renin-angiotensin-aldosterone system and fibrinolysis].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(12):683-8.
2000: Katja Lottermoser; Hans-Joerg Hertfelder; M Wehling; B Schiermeyer; Hans Vetter; Rainer Düsing
Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(4):357-60.
2000: Ioanna Gouni-Berthold; Heiner K. Berthold; Stefan Seewald; Claudia Seul; Yon Ko; Hans Vetter; Agapios Sachinidis
Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces.
Scandinavian journal of clinical and laboratory investigation 2000;60(8):723-31.
2000: Martin van Eickels; Hans Vetter; Christian Grohé
Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation.
British journal of pharmacology 2000;131(8):1592-6.
2000: Stefan Fronhoffs; J Luyken; K Steuer; ML Hansis; Hans Vetter; Peter Walger
The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients.
Intensive care medicine 2000;26(10):1566-70.
2000: S Un; Thomas Mengden; Hans Vetter
[Your patient self-monitors his blood pressure. Other limit values are applicable].
MMW Fortschritte der Medizin 2000;142(33-34):28-30.
2000: Burkhard Weisser; Thomas Mengden; Rainer Düsing; Hans Vetter; W Vetter
Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines.
American journal of hypertension 2000;13(8):940-3.
2000: Agapios Sachinidis; Claudia Seul; Ioanna Gouni-Berthold; Stefan Seewald; Yon Ko; Hans Vetter; J Fingerle; J Hoppe
Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.
British journal of pharmacology 2000;130(7):1561-70.
2000: S Kahlert; Simone Nuedling; Martin van Eickels; Hans Vetter; Rainer Meyer; Christian Grohe
Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway.
The Journal of biological chemistry 2000;275(24):18447-53.
2000: Yon Ko; Elisabeth Grünewald; Gudrun Totzke; M Klinz; Stefan Fronhoffs; Ioanna Gouni-Berthold; Agapios Sachinidis; Hans Vetter
High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis of illegitimate gene expression.
Oncology 2000;59(1):81-8.
2000: S Un; Thomas Mengden; K Glänzer; Hans Vetter
[Silent myocardial ischemia in hypertensive patients].
Praxis 2000;89(18):757-64.
2000: Agapios Sachinidis; Claudia Seul; Stefan Seewald; H Ahn; Yon Ko; Hans Vetter
Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma.
FEBS letters 2000;471(1):51-5.
2000: Katja Lottermoser; Hans-Joerg Hertfelder; Hans Vetter; Rainer Düsing
Fibrinolytic function in diuretic-induced volume depletion.
American journal of hypertension 2000;13(4 Pt 1):359-63.
2000: Yon Ko; B Koch; Volker Harth; Agapios Sachinidis; Ricarda Thier; Hans Vetter; Hermann M Bolt; Thomas Brüning
Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction.
Pharmacogenetics 2000;10(3):271-4.
2000: Thomas Neuhaus; Gudrun Totzke; Elisabeth Gruenewald; H P Juesten; Agapios Sachinidis; Hans Vetter; Yon Ko
Tumour necrosis factor-alpha gene expression and production in human umbilical arterial endothelial cells.
Clinical science (London, England : 1979) 2000;98(4):461-70.
2000: HP Jüsten; Elisabeth Grünewald; Gudrun Totzke; Ioanna Gouni-Berthold; A Sachinidis; D Wessinghage; Hans Vetter; K Schulze-Osthoff; Yon Ko
Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis.
Molecular cell biology research communications : MCBRC 2000;3(3):165-72.
2000: ME Ortiz-Pallardó; Yon Ko; Agapios Sachinidis; Hans Vetter; Hans-Peter Fischer; Hui Zhou
Detection of alpha-1-antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fixed and paraffin-embedded tissue: a comparison with immunohistochemical analysis.
Journal of hepatology 2000;32(3):406-11.
2000: Sebastian Stier; Gudrun Totzke; Elisabeth Grünewald; Thomas Neuhaus; Stefan Fronhoffs; Agapios Sachinidis; Hans Vetter; Klaus Schulze-Osthoff; Yon Ko
Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization.
FEBS letters 2000;467(2-3):299-304.
2000: ME Ortiz-Pallardó; Hui Zhou; Hans-Peter Fischer; T Neuhaus; Agapios Sachinidis; Hans Vetter; T Brüning; Yon Ko
Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach.
Journal of molecular medicine (Berlin, Germany) 2000;78(4):212-6.
2000: Volker Harth; S Donat; Yon Ko; Josef Abel; Hans Vetter; Thomas Brüning
NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.
Archives of toxicology 2000;73(10-11):528-31.
1999: Stefan Fronhoffs; Thomas Mengden; J Oliveira; Agapios Sachinidis; Hans Vetter
Cholesterol enhances contractile responses in isolated small mesenteric arteries of normotensive and spontaneously hypertensive rats.
Journal of hypertension 1999;17(12 Pt 2):1941-7.
1999: Agapios Sachinidis; Ioanna Gouni-Berthold; Claudia Seul; Stefan Seewald; Yon Ko; Udo Schmitz; Hans Vetter
Early intracellular signalling pathway of ethanol in vascular smooth muscle cells.
British journal of pharmacology 1999;128(8):1761-71.
1999: Thomas Brüning; Josef Abel; B Koch; K Lorenzen; Volker Harth; S Donat; A Sachinidis; Hans Vetter; Hermann M Bolt; Yon Ko
Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism.
Archives of toxicology 1999;73(8-9):427-30.
1999: Agapios Sachinidis; Ralf Kettenhofen; Stefan Seewald; Ioanna Gouni-Berthold; Udo Schmitz; Claudia Seul; Yon Ko; Hans Vetter
Evidence that lipoproteins are carriers of bioactive factors.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(10):2412-21.
1999: Simone Nuedling; S Kahlert; K Loebbert; Pieter A Doevendans; Rainer Meyer; Hans Vetter; Christian Grohé
17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo.
Cardiovascular research 1999;43(3):666-74.
1999: Uwe R Juergens; V Degenhardt; Meinolf Stöber; Hans Vetter
New insights in the bronchodilatory and anti-inflammatory mechanisms of action of theophylline.
Arzneimittel-Forschung 1999;49(8):694-8.
1999: Simone Nuedling; S Kahlert; K Loebbert; Rainer Meyer; Hans Vetter; Christian Grohé
Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes.
FEBS letters 1999;454(3):271-6.
1999: Yon Ko; Gudrun Totzke; Ioanna Gouni-Berthold; Agapios Sachinidis; Hans Vetter
Cytokine-inducible growth factor gene expression in human umbilical endothelial cells.
Molecular and cellular probes 1999;13(3):203-11.
1999: Martin van Eickels; Christian Grohé; K Löbbert; Michael Stimpel; Hans Vetter
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(5):394-9.
1999: Thomas Mengden; C Douven; Hans Vetter; Rainer Düsing
Evidence for structural alterations in resistance arteries of patients with severe congestive heart failure.
Journal of vascular research 1999;36(3):229-34.
1999: Stefan Seewald; Udo Schmitz; Claudia Seul; Yon Ko; Agapios Sachinidis; Hans Vetter
Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells.
American journal of hypertension 1999;12(5):532-7.
1999: Thomas Neuhaus; S Seewald; H Zhou; A Frechen; G Layer; Hans Vetter
[Cushing syndrome with occult ectopic ACTH production].
Praxis 1999;88(15):679-85.
1999: Agapios Sachinidis; M Carniel; Stefan Seewald; Claudia Seul; Ioanna Gouni-Berthold; Yon Ko; Hans Vetter
Lipid-induced changes in vascular smooth muscle cell membrane fluidity are associated with DNA synthesis.
Cell proliferation 1999;32(2-3):101-5.
1999: Hee Yul Ahn; K R Hadizadeh; Claudia Seul; Yeo-Pyo Yun; Hans Vetter; Agapios Sachinidis
Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
Molecular biology of the cell 1999;10(4):1093-104.
1999: Katja Lottermoser; B Wöstmann; Burkhard Weisser; Hans-Joerg Hertfelder; Udo Schmitz; Hans Vetter; Rainer Düsing
Effects of captopril on fibrinolytic function in healthy humans.
European journal of medical research 1999;4(1):31-4.
1999: Uwe R Juergens; Meinolf Stöber; Hans Vetter
Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
Respiration; international review of thoracic diseases 1999;66(3):220-4.
1998: Uwe R Juergens; Meinolf Stöber; Hans Vetter
The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases.
European journal of medical research 1998;3(12):539-45.
1998: Uwe R Juergens; Meinolf Stöber; Hans Vetter
Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro.
European journal of medical research 1998;3(11):508-10.
1998: Rainer Düsing; Burkhard Weisser; Thomas Mengden; Hans Vetter
Changes in antihypertensive therapy--the role of adverse effects and compliance.
Blood pressure 1998;7(5-6):313-5.
1998: Uwe R Juergens; Meinolf Stöber; L Schmidt-Schilling; T Kleuver; Hans Vetter
Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo.
European journal of medical research 1998;3(9):407-12.
1998: Yon Ko; M Klinz; Gudrun Totzke; Ioanna Gouni-Berthold; Agapios Sachinidis; Hans Vetter
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2141-6.
1998: Ralf Kettenhofen; M K Meyer zu Brickwedde; Yon Ko; Hans Vetter; Agapios Sachinidis
Identification of a phosphodiesterase I/nucleotide pyrophosphatase-related gene mRNA in rat vascular smooth muscle cells by the differential display approach.
Journal of molecular biology 1998;279(2):323-9.
1998: Thomas Neuhaus; S Seewald; Stefan Fronhoffs; F J Heidgen; Yon Ko; H Müller-Miny; Hans Vetter
[34-year-old patient with headache attacks and hypokalemic hypertension].
Der Internist 1998;39(6):650-4.
1998: Stefan Seewald; Claudia Seul; Ralf Kettenhofen; D Bokemeyer; Yon Ko; Hans Vetter; Agapios Sachinidis
Role of mitogen-activated protein kinase in the angiotensin II-induced DNA synthesis in vascular smooth muscle cells.
Hypertension 1998;31(5):1151-6.
1998: Christian Grohé; S Kahlert; K Löbbert; Ludwig Neyses; Martin van Eickels; Michael Stimpel; Hans Vetter
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
Journal of hypertension 1998;16(3):377-84.
1998: Katja Lottermoser; Burkhard Weisser; Hans-Joerg Hertfelder; B Wöstmann; Hans Vetter; Rainer Düsing
Antihypertensive drug treatment and fibrinolytic function.
American journal of hypertension 1998;11(3 Pt 1):378-84.
1998: AA Weber; Claudia Seul; Volker Harth; Yon Ko; Stefan Seewald; Hans Vetter; Agapios Sachinidis
Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
British journal of pharmacology 1998;123(5):906-10.
1998: Christian Grohé; S Kahlert; K Löbbert; Hans Vetter
Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis.
The Journal of endocrinology 1998;156(2):R1-7.
1997: Stefan Seewald; Agapios Sachinidis; Claudia Seul; Ralf Kettenhofen; Yon Ko; Hans Vetter
The role of platelet-derived growth factor-BB-induced increase in cytosolic free Ca2+ in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells.
Journal of hypertension 1997;15(12 Pt 2):1671-5.
1997: Christian Grohé; S Kahlert; K Löbbert; Michael Stimpel; Richard H Karas; Hans Vetter; Ludwig Neyses
Cardiac myocytes and fibroblasts contain functional estrogen receptors.
FEBS letters 1997;416(1):107-12.
1997: R Bramer; Stefan Fronhoffs; K Steuer; Peter Walger; Hans Vetter
[Severe soft tissue infection with bulla formation, sepsis, multiple organ failure].
Praxis 1997;86(41):1608-13.
1997: S Seewald; G Nickenig; Y Ko; Hans Vetter; Agapios Sachinidis
Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells.
Cardiovascular research 1997;36(1):92-100.
1997: Heike Zeitler; Yon Ko; C Zimmermann; G Nickenig; K Glänzer; Peter Walger; Agapios Sachinidis; Hans Vetter
Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.
European journal of medical research 1997;2(9):389-94.
1997: Agapios Sachinidis; Stefan Seewald; P Epping; Claudia Seul; Yon Ko; Hans Vetter
The growth-promoting effect of low-density lipoprotein may Be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway.
Molecular pharmacology 1997;52(3):389-97.
1997: Christian Grohé; S Kahlert; K Lóbbert; Martin van Eickels; Michael Stimpel; Hans Vetter; Ludwig Neyses
Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth.
British journal of pharmacology 1997;121(7):1350-4.
1997: R Kessler; S Leibhammer; O Laue; Agapios Sachinidis; W Siffert; H Hols; Hans Vetter; R Düsing
Acute saline infusion induces extracellular acidification and activation of the Na+/H+ exchanger in man.
European journal of clinical investigation 1997;27(7):558-65.
1997: Stefan Seewald; Agapios Sachinidis; R Düsing; Yon Ko; Claudia Seul; P Epping; Hans Vetter
Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells.
Atherosclerosis 1997;130(1-2):121-31.
1997: S Kahlert; Christian Grohé; Richard H Karas; K Löbbert; Ludwig Neyses; Hans Vetter
Effects of estrogen on skeletal myoblast growth.
Biochemical and biophysical research communications 1997;232(2):373-8.
1997: G Nickenig; G Geisen; Hans Vetter; Agapios Sachinidis
Characterization of angiotensin receptors on human skin fibroblasts.
Journal of molecular medicine (Berlin, Germany) 1997;75(3):217-22.
1997: Yon Ko; Bernhard Glodny; Sebastian Stier; Gudrun Totzke; G Nickenig; R Düsing; Agapios Sachinidis; Hans Vetter
Angiotensin type-1 (AT1) receptor gene expression in primarily cultured human arterial umbilical endothelial cells.
Biochemical pharmacology 1997;53(3):417-21.
1997: Georg Nickenig; Agapios Sachinidis; Frank Michaelsen; Michael Böhm; S Seewald; Hans Vetter
Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.
Circulation 1997;95(2):473-8.
1997: Heike Zeitler; Yon Ko; Bernhard Glodny; Gudrun Totzke; M Appenheimer; Agapios Sachinidis; Hans Vetter
Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers.
Cancer detection and prevention 1997;21(4):332-9.
1997: Agapios Sachinidis; M Liu; AA Weber; Claudia Seul; Volker Harth; Stefan Seewald; Yon Ko; Hans Vetter
Cholesterol enhances platelet-derived growth factor-BB-induced [Ca2+]i and DNA synthesis in rat aortic smooth muscle cells.
Hypertension 1997;29(1 Pt 2):326-33.
1996: Gudrun Totzke; Agapios Sachinidis; Hans Vetter; Yon Ko
Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression.
Molecular and cellular probes 1996;10(6):427-33.
1996: C Schmidt; Bernhard Baumeister; J Kipnowski; B Schiermeyer-Dunkhase; Hans Vetter
Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Hepato-gastroenterology 1996;43(12):1508-12.
1996: Agapios Sachinidis; Claudia Seul; Yon Ko; R Düsing; Hans Vetter
Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II-induced vascular smooth muscle cell growth.
British journal of pharmacology 1996;119(5):787-96.
1996: Agapios Sachinidis; Claudia Seul; Stefan Seewald; Yon Ko; Hans Vetter
Activation of Na+/H+ exchanger is not involved in the PDGF-BB-induced DNA-synthesis in vascular smooth muscle cells.
Biochemical and biophysical research communications 1996;227(2):468-72.
1996: K Kraft; S Schiessl; Hans Vetter
[Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
Praxis 1996;85(36):1081-6.
1996: Agapios Sachinidis; R Kraus; Claudia Seul; M K Meyer zu Brickwedde; K Schulte; Yon Ko; Jürgen Hoppe; Hans Vetter
Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
European journal of cell biology 1996;71(1):79-88.
1996: A A Weber; T Neuhaus; Claudia Seul; R Düsing; K Schrör; Agapios Sachinidis; Hans Vetter
Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells.
European journal of pharmacology 1996;309(2):209-13.
1996: Agapios Sachinidis; K B Schulte; Yon Ko; Claudia Seul; M K Meyer zu Brickwedde; R Düsing; Hans Vetter
Oligodeoxynucleotides directed to early growth response gene-1 mRNA inhibit DNA synthesis in the smooth muscle cell.
European journal of pharmacology 1996;309(1):95-105.
1996: Agapios Sachinidis; K el-Haschimi; Yon Ko; Claudia Seul; P Epping; Hans Vetter
Carbocyclic thromboxane A2 enhances the angiotensin II-induced DNA synthesis in smooth muscle cells.
European journal of pharmacology 1996;307(1):121-4.
1996: G Nickenig; Yon Ko; C Wanning; H Müller-Miny; K Zhou; Hans Vetter
[Isolated splenomegaly].
Der Internist 1996;37(6):632-5.
1996: Christian Grohé; S Kahlert; K Löbbert; Rainer Meyer; KW Linz; Richard H Karas; Hans Vetter
Modulation of hypertensive heart disease by estrogen.
Steroids 1996;61(4):201-4.
1996: Georg Nickenig; Agapios Sachinidis; Yon Ko; Hans Vetter
Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells.
European journal of pharmacology 1996;297(3):307-12.
1996: C Schmidt; T Fels; Bernhard Baumeister; Hans Vetter
The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
Current medical research and opinion 1996;13(7):417-25.
1995: Bernhard Baumeister; C Schmidt; B Schiermeyer-Dunkhase; Hans Vetter; J Kipnowski
Decreased gastric prostaglandin E2 synthesis in patients with gastric ulcers and in smokers.
Hepato-gastroenterology 1995;42(6):851-5.
1995: Yon Ko; Gudrun Totzke; Stefan Seewald; Udo Schmitz; B Schiermeyer; M K Meyer zu Brickwedde; Hans Vetter; Agapios Sachinidis
Native low-density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells.
European journal of cell biology 1995;68(3):306-12.
1995: Agapios Sachinidis; M Flesch; Yon Ko; K Schrör; M Böhm; R Düsing; Hans Vetter
Thromboxane A2 and vascular smooth muscle cell proliferation.
Hypertension 1995;26(5):771-80.
1995: F J Heidgen; Y D Ko; Stefan Fronhoffs; Hans Vetter
[Recurrent respiratory tract infections].
Praxis 1995;84(39):1079-82.
1995: C Schmidt; E Kosché; Bernhard Baumeister; Hans Vetter
Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
European journal of gastroenterology & hepatology 1995;7(9):865-9.
1995: Yon Ko; Gudrun Totzke; B Schiermeyer; H Zeitler; Udo Schmitz; Hans Vetter; Agapios Sachinidis
Reverse transcriptase-polymerase chain reaction (RT-PCR): a sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells.
Molecular and cellular probes 1995;9(4):215-22.
1995: Stefan Fronhoffs; D Bokemeyer; F J Heidgen; Hans Vetter
[Fever of unknown origin].
Praxis 1995;84(29-30):834-8.
1995: A Maass; Christian Grohé; Christian Kubisch; Bernd Wollnik; Hans Vetter; Ludwig Neyses
Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth.
European heart journal 1995;16 Suppl C():12-4.
1995: M Flesch; Yon Ko; Claudia Seul; R Düsing; H Feltkamp; Hans Vetter; Agapios Sachinidis
Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells.
European journal of pharmacology 1995;289(2):399-402.
1995: Burkhard Kreft; Torsten Sommer; M Vahlensieck; S Seewald; Hans Vetter; Hans Schild
[Turbo-spin-echo (TSE) sequences with selective fat suppression (SPIR) compared with chemical shift sequences in MRI for differentiation of adrenal tumors. Spectral Presaturation by Inversion Recovery].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1995;162(4):311-8.
1995: Udo Schmitz; Yon Ko; Stefan Seewald; K Glänzer; R Düsing; Hans Vetter
[Orthostatic hypotension].
Praxis 1995;84(9):264-8.
1995: S Seewald; R Kolloch; P M Klassen; Albert J Augustin; T Böker; Hans Vetter
[Progressive loss of vision in suspected tumor].
Der Internist 1995;36(1):53-5.
1995: G Hoffmann; Yon Ko; Agapios Sachinidis; B O Göbel; Hans Vetter; Dieter Rosskopf; Winfried Siffert; R Düsing
Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester.
The American journal of physiology 1995;268(1 Pt 1):C14-20.
1994: A Sachinidis; Y Ko; W Vetter; Hans Vetter
[Action of intrinsic low density lipoprotein in the vascular wall. Significance for the pathogenesis of essential hypertension and arteriosclerosis].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(12):662-7.
1994: D Bokemeyer; Stefan Fronhoffs; F J Heidgen; Hans Vetter
[Polyuria, polydipsia].
Praxis 1994;83(50):1418-21.
1994: M Flesch; Agapios Sachinidis; Y D Ko; K Kraft; Hans Vetter
Plasma lipids and lipoproteins and essential hypertension.
The Clinical investigator 1994;72(12):944-50.
1994: F J Heidgen; Stefan Seewald; Hans Vetter
[Abdominal pain, weight loss, tarry stools].
Praxis 1994;83(48):1355-8.
1994: Udo Schmitz; Yon Ko; Harald Becher; M Ludwig; Hans Vetter; R Düsing
Evidence for cardiovascular remodeling in a patient with Bartter's syndrome.
The Clinical investigator 1994;72(11):874-7.
1994: R Düsing; S Leibhammer; G Hoffmann; Hans Vetter; Winfried Siffert
Hypertonic saline infusion induces activation of the lymphocyte Na+/H+ antiport and cytosolic alkalinization in healthy human subjects.
The Clinical investigator 1994;72(11):817-21.
1994: A Maass; Christian Grohé; S Oberdorf; V P Sukhatme; Hans Vetter; Ludwig Neyses
Mitogenic signals control translation of the early growth response gene-1 in myogenic cells.
Biochemical and biophysical research communications 1994;202(3):1337-46.
1994: B O Göbel; G Hoffmann; M Ruppert; K O Stumpe; Hans Vetter; Winfried Siffert; R Düsing
The lymphocyte Na+/H+ antiport: activation in primary hypertension and during chronic NaCl-loading.
European journal of clinical investigation 1994;24(8):529-39.
1994: Udo Schmitz; Yon Ko; Stefan Seewald; R Düsing; Hans Vetter
Iron-deficiency anemia as the sole manifestation of celiac disease.
The Clinical investigator 1994;72(7):519-21.
1994: Christian Grohé; J Nouskas; Hans Vetter; Ludwig Neyses
Effects of nisoldipine on endothelin-1- and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes.
Journal of cardiovascular pharmacology 1994;24(1):13-6.
1994: M Flesch; A Low; Andreas Hirner; Hans Vetter
[Isolated mesenteric fibromatosis].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1994;83(22):684-6.
1994: A Hammes; S Oberdorf; E E Strehler; T Stauffer; Ernesto Carafoli; Hans Vetter; Ludwig Neyses
Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1994;8(6):428-35.
1994: R Oertel; Stefan Seewald; C Schmidt; F J Heidgen; Hans Vetter
[Cough, vomiting, rapid weight loss].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1994;83(9):254-8.
1994: Y D Ko; Stefan Seewald; H Stiebler; Agapios Sachinidis; Hans Vetter
[Bone pain, polydipsia, polyuria].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1994;83(7):193-6.
1994: Stefan Seewald; Udo Schmitz; Yon Ko; Hans Vetter
[Headache].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1994;83(6):163-6.
1994: Georg Nickenig; Yon Ko; W Nettekoven; M Appenheimer; B Schiermeyer; Hans Vetter; Agapios Sachinidis
Oxymetazoline enhances epidermal- and platelet-derived growth factor-induced DNA synthesis.
Atherosclerosis 1994;105(1):71-7.
1994: K Kraft; Hans Vetter
Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension: moxonidine versus captopril.
Journal of cardiovascular pharmacology 1994;24 Suppl 1():S29-33.
1993: Yon Ko; Gudrun Totzke; K Schulte; B Schiermeyer; M K Meyer zu Brickwedde; Hans Vetter; Agapios Sachinidis
Lipoprotein-induced expression of the sis oncogene in human arterial endothelial cells.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S132-3.
1993: Agapios Sachinidis; Yon Ko; K B Schulte; M Appenheimer; Claudia Seul; M K Meyer zu Brickwedde; Georg Nickenig; Hans Vetter
Effects of lipoproteins on the expression of the early growth response gene-1 and on DNA synthesis in rat vascular smooth muscle cells.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S116-7.
1993: Christian Kubisch; Bernd Wollnik; A Maass; Rainer Meyer; Hans Vetter; Ludwig Neyses
Immediate-early gene induction by repetitive mechanical but not electrical activity in adult rat cardiomyocytes.
FEBS letters 1993;335(1):37-40.
1993: Yon Ko; Gudrun Totzke; G H Graack; F J Heidgen; M K Meyer zu Brickwedde; R Düsing; Hans Vetter; Agapios Sachinidis
Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
Journal of hypertension 1993;11(11):1171-8.
1993: E Schmidt-Hengst; W Sauer; C Schmidt; Hans Vetter
[Diarrhea].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(37):1016-8.
1993: Ludwig Neyses; J Nouskas; J Luyken; S Fronhoffs; S Oberdorf; U Pfeifer; R S Williams; V P Sukhatme; Hans Vetter
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes.
Journal of hypertension 1993;11(9):927-34.
1993: S Seewald; C Schmidt; P M Klassen; J Vogel; Hans Vetter
[Diarrhea].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(31):825-7.
1993: Bernd Wollnik; Christian Kubisch; A Maass; Hans Vetter; Ludwig Neyses
Hyperosmotic stress induces immediate-early gene expression in ventricular adult cardiomyocytes.
Biochemical and biophysical research communications 1993;194(2):642-6.
1993: Yon Ko; H Stiebler; Georg Nickenig; A J Wieczorek; Hans Vetter; Agapios Sachinidis
Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells.
American journal of hypertension 1993;6(6 Pt 1):496-9.
1993: Stefan Seewald; Hans Vetter
[Back pain].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(20):593-6.
1993: Yon Ko; Agapios Sachinidis; A J Wieczorek; M Appenheimer; R Düsing; Hans Vetter
Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat.
The Clinical investigator 1993;71(5):379-82.
1993: Agapios Sachinidis; Yon Ko; A Wieczorek; B Weisser; R Locher; W Vetter; Hans Vetter
Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat.
Biochemical and biophysical research communications 1993;192(2):794-9.
1993: Yon Ko; W Nettekoven; R Christian; A J Wieczorek; R Düsing; Hans Vetter; Agapios Sachinidis
Long-term insulin treatment of vascular smooth muscle cells from rat aorta attenuates the synergistic effect of insulin on angiotensin II- and epidermal growth factor-induced DNA synthesis.
Clinical science (London, England : 1979) 1993;84(4):435-40.
1993: Agapios Sachinidis; K Schulte; Yon Ko; M K Meyer zu Brickwedde; Viviane Hoppe; Jürgen Hoppe; Hans Vetter
The induction of early response genes in rat smooth muscle cells by PDGF-AA is not sufficient to stimulate DNA-synthesis.
FEBS letters 1993;319(3):221-4.
1993: Yon Ko; R Häring; H Stiebler; A J Wieczorek; Hans Vetter; Agapios Sachinidis
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells.
Atherosclerosis 1993;99(2):253-9.
1993: Agapios Sachinidis; Yon Ko; P Weisser; M K Meyer zu Brickwedde; R Düsing; R Christian; A J Wieczorek; Hans Vetter
EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
Journal of hypertension 1993;11(2):155-62.
1993: R Düsing; M Sorger; L Mattes; B O Göbel; G Hoffmann; Dieter Rosskopf; Hans Vetter; Winfried Siffert
Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.
The Clinical investigator 1993;71(2):119-25.
1992: Ludwig Neyses; Hans Vetter
Molecular biology of oncogenes and cardiovascular hypertrophy.
Journal of hypertension 1992;10(12):1447-52.
1992: Agapios Sachinidis; P Weisser; Yon Ko; K Schulte; K Meyer zu Brickwedde; Ludwig Neyses; Hans Vetter
Angiotensin II induces formation of the early growth response gene-1 protein in rat vascular smooth muscle cells.
FEBS letters 1992;313(2):109-12.
1992: K Kraft; Hans Vetter
[Advantages of 24-hour ambulatory blood pressure monitoring for the assessment of dose-effect relations and dose-equivalency].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1992;81(47):1430-4.
1992: G Hoffmann; B O Göbel; U Harbrecht; Hans Vetter; R Düsing
Platelet cAMP and cGMP in essential hypertension.
American journal of hypertension 1992;5(11):847-50.
1992: Yon Ko; A Görg; M Appenheimer; A J Wieczorek; R Düsing; Hans Vetter; Agapios Sachinidis
Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
European journal of pharmacology 1992;227(2):215-9.
1992: Agapios Sachinidis; Yon Ko; W Nettekoven; A J Wieczorek; R Düsing; Hans Vetter
The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar-Kyoto rats.
Journal of hypertension 1992;10(10):1159-64.
1992: R Düsing; B O Göbel; G Hoffmann; Hans Vetter; Winfried Siffert
[Clinical importance of the Na+/H(+) antiporter].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(7):378-84; 390.
1992: M Ludwig; K O Stumpe; A Sauer; R Kolloch; U Goertz; Hans Vetter
Effects of a high-cholesterol diet on arterial wall thickness and vascular reactivity in young rabbits.
The Clinical investigator 1992;70(2):105-12.
1992: Y D Ko; Agapios Sachinidis; G H Graack; M Appenheimer; A J Wieczorek; R Düsing; Hans Vetter
Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers.
The Clinical investigator 1992;70(2):113-7.
1992: B Weisser; G Kayser; S Wagner; B O Göbel; Hans Vetter; R Düsing
Inhibition of cyclooxygenase attenuates baroreceptor function and increases the pressor response to norepinephrine in man.
European journal of clinical pharmacology 1992;42(6):681-3.
1992: Agapios Sachinidis; Y Ko; G K Graack; A J Wieczorek; Hans Vetter
Action of metoprolol, enalapril, diltiazem, verapamil, and nifedipine on cell growth of vascular smooth muscle cells.
Journal of cardiovascular pharmacology 1992;19 Suppl 2():S60-2.
1991: Agapios Sachinidis; A Görg; Yon Ko; A J Wieczorek; R Düsing; Hans Vetter
Effect of the angiotensin II receptor antagonist MK 954 on the angiotensin II-induced increase in free cytosolic Ca2+ and growth in vascular smooth muscle cells.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S226-7.
1991: Agapios Sachinidis; Yon Ko; A J Wieczorek; R Locher; M Appenheimer; Hans Vetter; W Vetter
The maximal stimulatory effect of low-density lipoprotein on the cytosolic free calcium ion depends on the presence of its lipid and protein component.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S186-7.
1991: M Ludwig; K O Stumpe; A Sauer; R Kolloch; U Goertz; Hans Vetter
Short-term high dietary cholesterol in early life induces persistent increases in arterial wall thickness and vascular reactivity to noradrenaline.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S136-7.
1991: Ludwig Neyses; J Nouskas; Hans Vetter
Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1.
Biochemical and biophysical research communications 1991;181(1):22-7.
1991: R Düsing; Hans Vetter
[Hypertension. Individualized treatment as a new therapy concept].
Der Internist 1991;32(3):135-8.
1991: T Lehnert; C Schmidt; A Overlack; Bettina Siewert; Hans Vetter
[Chronic hemorrhagic pleural effusion in mediastinal pancreatic pseudocyst].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1991;80(5):82-4.
1991: B O Göbel; A Schulte-Göbel; B Weisser; K Glänzer; Hans Vetter; R Düsing
Arterial blood pressure. Correlation with erythrocyte count, hematocrit, and hemoglobin concentration.
American journal of hypertension 1991;4(1 Pt 1):14-9.
1991: M Ludwig; A Sauer; K O Stumpe; Hans Vetter
[Behavior of arterial vascular contractility in the course of structural vascular changes during a cholesterol diet].
VASA. Supplementum 1991;33():153-4.
1991: B O Göbel; G Hoffmann; M Ruppert; K O Stumpe; Hans Vetter; R Düsing
Membrane transport, sodium balance, and blood pressure regulation.
Klinische Wochenschrift 1991;69 Suppl 25():84-9.
1990: R Oertel; A Overlack; Hans Vetter
[Fever, productive cough, chest pain].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1990;79(47):1473-5.
1990: B Weisser; P Velling; C Geller; K Kraft; B Göbel; Hans Vetter; R Düsing
Pseudohypertension in hypertensive patients on multiple drug therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S79-81.
1990: A Leuwer; B Weisser; Bettina Siewert; Hans Vetter; R Düsing
[Acute purulent parotitis as a sequela of alkylphosphate (E 605) poisoning].
Laryngo- rhino- otologie 1990;69(9):468-71.
1990: Ludwig Neyses; Hans Vetter
Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S99-102.
1990: R Düsing; A Struck; B O Göbel; B Weisser; Hans Vetter
Effects of n-3 fatty acids on renal function and renal prostaglandin E metabolism.
Kidney international 1990;38(2):315-9.
1990: B Braun-Dreuw; Hans Vetter
[Painless increase of abdominal girth].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1990;79(16):503-4.
1990: G Hoffmann; R Pietsch; B O Göbel; B Weisser; G Bönner; Hans Vetter; R Düsing
Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
European journal of pharmacology 1990;178(1):79-83.
1990: R Nati; R Kolloch; Hans Vetter
[Cough, dyspnea, hemoptysis].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1990;79(7):175-8.
1990: C Grohe; A Overlack; Hans Vetter
[Weight loss, fever, dyspnea].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1990;79(5):111-3.
1990: R Düsing; K O Stumpe; Hans Vetter
Dietary fat, hypertension, atherosclerosis.
Klinische Wochenschrift 1990;68 Suppl 20():1-3.
1990: B Weisser; A Struck; B O Göbel; Hans Vetter; R Düsing
Fish oil and baroreceptor function in man.
Klinische Wochenschrift 1990;68 Suppl 20():49-52.
1990: B Weisser; P Lieder; B Göbel; Hans Vetter; R Düsing
Baroreceptor activity in man during administration of the calcium channel blocker felodipine.
International journal of clinical pharmacology research 1990;10(6):325-30.
1989: Ludwig Neyses; Hans Vetter
Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S104-5.
1989: Ludwig Neyses; Hans Vetter
Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes.
Biochemical and biophysical research communications 1989;163(3):1435-43.
1988: R Düsing; B Göbel; B Weisser; D Dittrich; S Kraemer; Hans Vetter
[Mechanism and significance of arteriolar media hypertrophy/ hyperplasia in arterial hypertension. Role of the Na+/H+ antiport].
Klinische Wochenschrift 1988;66(23):1151-9.